![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Gilbert Mark R
Publisher: Informa Healthcare
ISSN: 1473-7175
Source: Expert Review of Neurotherapeutics, Vol.13, Iss.4, 2013-04, pp. : 353-355
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemotherapy and Delivery in the Treatment of Primary Brain Tumors
Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa
By Shoji Mamoru Sun Aiming Kisiel Walter Lu Yang Shim Hyunsuk McCarey Bernard Nichols Christopher Parker Ernest Pohl Jan Mosley Cara Alizadeh Aaron Liotta Dennis Snyder James
Journal of Drug Targeting, Vol. 16, Iss. 3, 2008-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Chang Susan M. Kuhn John G. Ian Robins H. Clifford Schold S. Spence Alexander M. Berger Mitchel S. Mehta Minesh P. Pollack Ian Gilbert Mark Prados Michael D.
Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. :